e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Pulmonary circulation: clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension
N. Nickel, P. Kümpers, H. Golpon, K. Olsson, M. Hoeper (Germany)
Source:
Annual Congress 2010 - Pulmonary circulation: clinical aspects
Session:
Pulmonary circulation: clinical aspects
Session type:
E-Communication Session
Number:
5601
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Nickel, P. Kümpers, H. Golpon, K. Olsson, M. Hoeper (Germany). Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 5601
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Should we screen for hereditary pulmonary hypertension?
Related content which might interest you:
Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007
Prognostic implications of delayed heart rate recovery from maximal-incremental exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008
Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Evaluation of thyroid function in pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009
Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 704-713
Year: 2014
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Early improvements predict outcomes in pulmonary arterial hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
The importance of cardiac function in pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1483-1485
Year: 2010
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007
Prognosis in pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 971-972
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept